NCT04868955 is a NA clinical trial of Oral screen training in Stroke, sponsored by Rebecca Norrman and Elin Rova.

Who is sponsoring NCT04868955?

NCT04868955 is sponsored by Rebecca Norrman and Elin Rova.

What drugs are being tested in NCT04868955?

Interventions in NCT04868955: Oral screen training.

What condition does NCT04868955 study?

NCT04868955 studies Stroke, Dysphagia.

Is NCT04868955 still recruiting?

NCT04868955 is currently status unknown. Last updated 3 May 2021.

Last reviewed 2021-05-03 · How we verify

NCT04868955

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Oral Screen Training With IQoro as Treatment for Dysphagia After Stroke

Status unknown NA Last updated 3 May 2021

What this trial tests

NA trial testing Oral screen training in Stroke in 24 participants. Status unknown.

Timeline

26 April 2019

Primary endpoint
3 May 2021

3 May 2021

Quick facts

Lead sponsor	Rebecca Norrman and Elin Rova
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	26 April 2019
Primary completion	3 May 2021
Estimated completion	3 May 2021
Sites	1 location across Sweden

Drugs / interventions tested

Oral screen training

Conditions studied

Stroke — all drugs for Stroke →
Dysphagia — all drugs for Dysphagia →

Sponsor

Rebecca Norrman and Elin Rova

Who can join

18 and older, any sex, with Stroke or Dysphagia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose The purpose of the study is to evaluate if training with oral screen IQoro® improves swallowing in patients with dysphagia after stroke. Method Inpatient from a stroke unit in Sweden who have been assessed with fiberoptic endoscopic evaluation of swallowing(FEES) which proves swallowing difficulties (dysphagia) were recruited. The participants were randomise to control- or intervention group. Both groups received usual care. The intervention group were instructed to oral screen (IQoro®) training for 13 weeks. Follow up with FEES was made 13 weeks post of recruitment. The assess with FEES was recorded and the recordings are going to be analyzed afterwards to compare the swallowing ability between baseline and follow up in group and between group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04868955 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rebecca Norrman and Elin Rova
Last refreshed: 3 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04868955.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing